Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support : vimarsana.com

In a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.

Related Keywords

United States , , International Classification Of Diseases , National Cohort , Academia Research Generation Consortium , National Institute Of Health , World Health Organization , Inpatients With , Image Credit , National Institute , Randomized Evaluation , Academia Research Generation , International Classification , Tenth Revision , Breathing , Oronavirus Disease Covid 19 , Examethasone , Ortality , Oronavirus , Orticosteroid , Cmo , Ospice , Ospital , Xygen , Lacebo , Emdesivir , Esearch , Espiratory , Espiratory Illness , Ars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Herapeutics ,